πŸ‡ΊπŸ‡Έ FDA
Patent

US 6825165

Betacellulin modification

expired A61KA61K38/00

Quick answer

US patent 6825165 (Betacellulin modification) held by Takeda Chemical Industries Ltd. expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Takeda Chemical Industries Ltd.
Grant date
Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00